Clayton Utz

A judge hearing a suit against Lovisa has questioned whether it should proceed as a class action, but shut down a 'pejorative remark' by the jewellery chain's barrister about Fair Work class actions.

Pharmaceutical giant Lundbeck has resolved its battle with Novartis unit Sandoz over top-selling drug Lexapro, a battle that has raged for years and across multiple courts.

The administrators for the operator of the Callide power station have won extra time to convene a second creditors meeting after the court heard they may soon be able to put to rest a series of complex disputes over the Queensland power station.

US drug maker Allergan may defend a class action over recalled textured breast implants by arguing its knowledge of the alleged defects was limited by the state of scientific knowledge at the time the products were made.

Australia’s largest brick manufacturer Brickworks has dropped a central claim in its competition lawsuit against a rival founded by billionaire Len Buckeridge. 

Japanese car maker Isuzu has struck back at a class action, arguing Isuzu D-Max and MU-X cars sold in Australia did not contain the features of so-called defeat devices used to cheat on emissions tests.

The Full Court has poured cold water on Vittoria Cantarella's hopes of reviving its ‘Oro’ trade marks, finding a judge did not err in concluding the marks were already used by another coffee maker.

Risk advisory expert Doug Nixon has joined Clayton Utz as a partner after 20 years at Ernst & Young.

The heirs of iron ore magnate Peter Wright have won a bid to haul their brother Julian to court to question him about the identity of the funder who backed his unsuccessful case against them in a dispute over their father’s estate.